Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages
DOWNLOAD
Download Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page
Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages
DOWNLOAD
Author : United States. Congress
language : en
Publisher: Createspace Independent Publishing Platform
Release Date : 2017-10
Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages written by United States. Congress and has been published by Createspace Independent Publishing Platform this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017-10 with categories.
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages
DOWNLOAD
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
language : en
Publisher:
Release Date : 2013
Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2013 with Biological products categories.
Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages
DOWNLOAD
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
language : en
Publisher:
Release Date : 2013
Review Of The Proposed Generic Drug And Biosimilars User Fees And Further Examination Of Drug Shortages written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2013 with Biologicals categories.
Activity Report Of The Committee On Energy And Commerce Of The U S House Of Representatives Together With Dissenting Views
DOWNLOAD
Author : United States. Congress. House. Committee on Energy and Commerce
language : en
Publisher:
Release Date : 2012
Activity Report Of The Committee On Energy And Commerce Of The U S House Of Representatives Together With Dissenting Views written by United States. Congress. House. Committee on Energy and Commerce and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012 with Energy policy categories.
Making Medicines Affordable
DOWNLOAD
Author : National Academies of Sciences, Engineering, and Medicine
language : en
Publisher: National Academies Press
Release Date : 2018-03-01
Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-03-01 with Medical categories.
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Daily Digest
DOWNLOAD
Author :
language : en
Publisher: Government Printing Office
Release Date :
Daily Digest written by and has been published by Government Printing Office this book supported file pdf, txt, epub, kindle and other format this book has been release on with categories.
Congressional Record
DOWNLOAD
Author : United States. Congress
language : en
Publisher:
Release Date :
Congressional Record written by United States. Congress and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on with Law categories.
The Congressional Record is the official record of the proceedings and debates of the United States Congress. It is published daily when Congress is in session. The Congressional Record began publication in 1873. Debates for sessions prior to 1873 are recorded in The Debates and Proceedings in the Congress of the United States (1789-1824), the Register of Debates in Congress (1824-1837), and the Congressional Globe (1833-1873)
Legislative Calendar
DOWNLOAD
Author : United States. Congress. House. Committee on Energy and Commerce
language : en
Publisher:
Release Date : 2009
Legislative Calendar written by United States. Congress. House. Committee on Energy and Commerce and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2009 with categories.
Congress And The Nation 2009 2012 Volume Xiii
DOWNLOAD
Author : Dave Tarr
language : en
Publisher: CQ Press
Release Date : 2014-09-09
Congress And The Nation 2009 2012 Volume Xiii written by Dave Tarr and has been published by CQ Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-09-09 with Political Science categories.
Chronicling the highly partisan and polarized environment during the historic first term of President Barack Obama, Congress and the Nation 2009-2012 Volume XIII is the most authoritative reference on congressional law-making and trends during the 111th and 112th Congresses. The newest edition in this award-winning series documents the most fiercely debated issues during this period, including: Stimulus spending in the wake of financial crisis The controversial reform of the U.S. healthcare system Showdowns over raising the national debt ceiling Extensions of tax cuts and unemployment compensation Confirmation of two new female members of the U.S. Supreme Court Overhaul of financial industry regulations Repeal of the “don’t ask, don’t tell” law banning openly gay armed forces personnel from military service This acclaimed resource also covers the shift in partisan control of the U.S. House after the 2010 midterm election and the subsequent gridlock for lawmaking in the 112th Congress. Organized by policy area, each chapter summarizes the legislative activity, including a chronology and legislative history of the bills passed and the major provisions of the final laws. No other source guides readers seamlessly through the policy output of the national legislature with the breadth, depth, and authority of Congress and the Nation. This must-have reference for all academic libraries meets the needs of the full spectrum of users, from lower-level undergraduates through researchers and faculty.
Pharmaceutical Economics And Policy
DOWNLOAD
Author : Stuart O. Schweitzer
language : en
Publisher: Oxford University Press
Release Date : 2018-05-01
Pharmaceutical Economics And Policy written by Stuart O. Schweitzer and has been published by Oxford University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-05-01 with Business & Economics categories.
Pharmaceuticals constitute a relatively small share of the total healthcare expenditure in most developed economies, and yet they play a critical role in the ongoing debate over how best to advance, improve, and afford healthcare. Despite this, and perhaps because of this, the industry has had, for many years, an outsized claim to fame and controversy, praise and criticisms, support and condemnation. Unfortunately, many participants in the debate do not fully understand the complexities of the industry and its role in the overall healthcare system. The analytical tools of economics provide a strong foundation for a better understanding of the dynamics of the pharmaceutical industry, its contribution to health and healthcare, its dual and often conflicting priorities of affordability and innovation, as well as the various private and public policy initiatives directed at the sector. This third edition of a uniquely comprehensive and balanced examination of the industry includes several new chapters on important topics such as the full-fledged generics sector, the arrival of biosimilars or generic biological drugs, the global consolidation of manufacturers, the evolving reimbursement landscape, and the emergence of the world's most populous nations, such as China, India, and Brazil, as both suppliers and consumers of pharmaceutical products. Other chapters have been fully rewritten or extensively updated, covering such important topics as the cost efficiency of research and development, pace of new innovations, economic evaluation and value-based pricing of drugs, and public and private interventions in the industry.